Addex Therapeutics (ADXN) Revenue (2019 - 2025)

Addex Therapeutics has disclosed Revenue across 7 years of filings, most recently posting $310.29 for Q4 2025.

• Revenue for Q4 2025 came in at $310.29, down 81.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $101329.0 (down 77.9% YoY), and the FY2025 annual result was $36150.1, down 92.16% from the prior year.
• Revenue came in at $310.29 for Q4 2025 at Addex Therapeutics, down from $37158.3 in the prior quarter.
• In the past five years, Revenue ranged from a high of $3.4 million in Q4 2021 to a low of $310.29 in Q4 2025.
• The 5-year median for Revenue is $319268.8 (2024), against an average of $552993.0.
• Across the five-year window, Revenue soared 2407.84% in 2021 and slumped 99.0% in 2024, its largest moves.
• Addex Therapeutics' Revenue stood at $3.4 million in 2021, then plunged by 82.02% to $614955.3 in 2022, then tumbled by 71.87% to $172993.7 in 2023, then plunged by 99.0% to $1721.4 in 2024, then tumbled by 81.97% to $310.29 in 2025.
• The last three Revenue figures came in at $310.29 (Q4 2025), $37158.3 (Q3 2025), and $1721.4 (Q4 2024), per Business Quant data.